$27.8M Xarelto Verdict
December 7, 2017
On December 5, 2017, a Philadelphia pharmaceutical liability jury returned its verdict in the amount of $27.8 million in favor of a husband and wife regarding the wife’s internal bleeding allegedly caused by her use of the prescription blood-thinning medication Xarelto (rivaroxaban). The jury [...]
Continue Reading
Maryland County Announces Plan To Sue Opioid Manufacturers
September 19, 2017
On September 6, 2017, Anne Arundel County, Maryland (the Maryland county in which the state capital, Annapolis, is located) announced its intention to pursue legal action against opioid manufacturers, distributors, and local “pill mill” doctors who have contributed to the worsening opioi[...]
Continue Reading
$417M Johnson & Johnson Baby Powder Ovarian Cancer Verdict
August 22, 2017
A California jury returned its verdict on August 21, 2017 in the amount of $417 million in favor of a woman who had used Johnson & Johnson Baby Powder for decades and later developed ovarian cancer. The California jury’s verdict included $70 million in compensatory damages and an additiona[...]
Continue Reading
First Xarelto Trial Results In Win For The Defendants
May 25, 2017
On May 3, 2017, a federal jury in Louisiana found against a Xarelto plaintiff who claimed that the defendants, Johnson & Johnson (“J & J”) and Bayer AG, had inadequately warned him regarding the internal bleeding risk associated with Xarelto, a blood-thinning medication that has [...]
Continue Reading
$3M Paxil Labeling Verdict For Suicide Death
May 9, 2017
On April 20, 2017, a Chicago jury returned its verdict in the amount of $3 million in favor of a widow whose 57-year-old husband was a corporate attorney who committed suicide while taking a generic version of Paxil, by stepping into the path of a train on July 15, 2010. The defendant was GlaxoSmith[...]
Continue Reading
$110M Missouri Talc Verdict Against Johnson & Johnson
May 6, 2017
On May 4, 2017, a Missouri talcum powder jury returned its verdict in favor of the plaintiff in the amount of $110 million against Johnson & Johnson (“J & J”), finding that J & J failed to adequately warn the woman about the risk of cancer associated with use of talc-based pr[...]
Continue Reading
$20M Philadelphia Pelvic Mesh Verdict
May 1, 2017
A Philadelphia product liability jury returned its verdict on April 28, 2017 in the amount of $20 million in favor of the 56-year-old New Jersey plaintiff after a three-week trial of her pelvic mesh lawsuit against Johnson & Johnson and its subsidiary, Ethicon. The jury’s verdict included [...]
Continue Reading
